Stockreport

NRx Pharmaceuticals, Inc. (NRXP) Discusses Regulatory Update and Development Pipeline Expansion for Preservative-Free Ketamine Formulation Transcript [Seeking Alpha]

NRX Pharmaceuticals, Inc.  (NRXP) 
PDF Company Participants Brian Korb Jonathan Javitt - Co-Founder, Chief Scientist Officer, Chairman & Interim CEO Conference Call Participants Patrick Trucchio - H. [Read more]